Home›Search›Biomedicine and Pharmacotherapy

Biomedicine and Pharmacotherapy

Elsevier Masson s.r.l. · France

ISSN0753-3322eISSN1950-6007

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ Open Access

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (2 more)+12

⚠ Withdrawn from DOAJ-15

Total75

Third-party records · how this is calculated · Report an error →

Removed from DOAJ (2024-11-26). DOAJ's stated reason: Journal not adhering to Best practice. A removal from the Directory of Open Access Journals is a quality/transparency signal — it can mean the journal became inactive or failed DOAJ's re-review criteria. This is not proof of predatory practice, but verify the journal's current status and policies before submitting. Check on DOAJ ↗

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

2.074

H-Indexi

218

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.561

Total Worksi

20,210

Total Citationsi

645,150

2yr Mean Citednessi

7.16

Open Impact Factor alternative

Aims & Scope

Subject areas: Medicine, Research & Experimental; Pharmacology & Pharmacy; Medicine (miscellaneous); Pharmacology.

General Information

Country / RegionFrance

Primary Language—

1st Year Published—

FrequencyTen No. A Year

StatusActive

Total Publications20,210

Publisher OrgElsevier BV

Visit Journal Website

Submission Info

Publishing ModelGold Open Access

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/12 · 42%

✅

Do you know the journal / publisher?

Elsevier Masson s.r.l.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

0753-3322 / 1950-6007

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1.3k

64k

2019

1.4k

68k

2020

1.4k

58k

2021

1.6k

49k

2022

1.9k

48k

2023

1.7k

23k

2024

1.1k

3.8k

2025

766

154

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q1

PharmacologyQ1

Subject Classification

Web of Science Categories

Medicine, Research & ExperimentalPharmacology & Pharmacy

Scopus Categories

PharmacologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Cancer-related molecular mechanisms researchMicroRNA in disease regulationCircular RNAs in diseasesRNA modifications and cancerLiver Disease Diagnosis and Treatment

Frequently asked questions about Biomedicine and Pharmacotherapy

Is Biomedicine and Pharmacotherapy a predatory journal?

Biomedicine and Pharmacotherapy was withdrawn from the Directory of Open Access Journals (DOAJ) — DOAJ's stated reason: "Journal not adhering to Best practice" (2024-11-26). Withdrawal is not a predatory verdict, but it is a material editorial signal; it remains indexed in Web of Science, Scopus. Verify the journal's current status on DOAJ and its official site before submitting.

What is the impact factor of Biomedicine and Pharmacotherapy?

Biomedicine and Pharmacotherapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 7.16.

Is Biomedicine and Pharmacotherapy indexed in Scopus and Web of Science?

Biomedicine and Pharmacotherapy is indexed in Web of Science, Scopus.

What is the aims and scope of Biomedicine and Pharmacotherapy?